A quasi‐experimental trial of the clinical and economic impact of implementing of hepatitis B immunoglobulin policy post needle stick and sharp injuries in reducing its unnecessary use at a tertiary care hospital. Issue 10 (29th June 2021)
- Record Type:
- Journal Article
- Title:
- A quasi‐experimental trial of the clinical and economic impact of implementing of hepatitis B immunoglobulin policy post needle stick and sharp injuries in reducing its unnecessary use at a tertiary care hospital. Issue 10 (29th June 2021)
- Main Title:
- A quasi‐experimental trial of the clinical and economic impact of implementing of hepatitis B immunoglobulin policy post needle stick and sharp injuries in reducing its unnecessary use at a tertiary care hospital
- Authors:
- Alshehail, Bashayer
Alotaibi, Nouf
Joseph, Royes
Alshayban, Dhafer - Abstract:
- SUMMARY: Introduction: Hepatitis B virus infection has the highest rate of transmission out of the blood‐borne viruses in health care workers. Exposure to HBsAg positive source should be managed based on Hepatitis B serology results. Given that Hepatitis B immunoglobulin (HBIG) is an expensive medication with limited stock levels, it should be given more attention to make sure of its optimum use. This trial aims to evaluate the effectiveness of a policy on the use of HBIG following needle stick and sharp injuries among health care workers. Methods: It is a quasi‐experimental trial conducted at a Tertiary Care hospital in Saudi Arabia. The participants were health care workers who received HBIG following needle stick and sharp injuries from January 2018 to May 2020. Before and after implementing departmental guidelines and education on the post‐exposure procedure, the trial re‐evaluated the need for HBIG among the receivers. Results: A total of 60 health care workers received HBIG for needle stick and sharp injuries between the trial period (pre‐ and post‐implementation). The percentage of patients who received inappropriate HBIG was significantly lower during the post‐implementation of the guideline (30%) than that among the pre‐implementation period (60%). Thus, the direct cost associated with the inappropriate use was reduced from SAR 30000 to SAR 13500 post‐implementation. Conclusion: The implementation of HBIG guidelines of use and education has led to a statisticallySUMMARY: Introduction: Hepatitis B virus infection has the highest rate of transmission out of the blood‐borne viruses in health care workers. Exposure to HBsAg positive source should be managed based on Hepatitis B serology results. Given that Hepatitis B immunoglobulin (HBIG) is an expensive medication with limited stock levels, it should be given more attention to make sure of its optimum use. This trial aims to evaluate the effectiveness of a policy on the use of HBIG following needle stick and sharp injuries among health care workers. Methods: It is a quasi‐experimental trial conducted at a Tertiary Care hospital in Saudi Arabia. The participants were health care workers who received HBIG following needle stick and sharp injuries from January 2018 to May 2020. Before and after implementing departmental guidelines and education on the post‐exposure procedure, the trial re‐evaluated the need for HBIG among the receivers. Results: A total of 60 health care workers received HBIG for needle stick and sharp injuries between the trial period (pre‐ and post‐implementation). The percentage of patients who received inappropriate HBIG was significantly lower during the post‐implementation of the guideline (30%) than that among the pre‐implementation period (60%). Thus, the direct cost associated with the inappropriate use was reduced from SAR 30000 to SAR 13500 post‐implementation. Conclusion: The implementation of HBIG guidelines of use and education has led to a statistically significant decrease in its inappropriate use and led to cost reduction. … (more)
- Is Part Of:
- International journal of clinical practice. Volume 75:Issue 10(2021)
- Journal:
- International journal of clinical practice
- Issue:
- Volume 75:Issue 10(2021)
- Issue Display:
- Volume 75, Issue 10 (2021)
- Year:
- 2021
- Volume:
- 75
- Issue:
- 10
- Issue Sort Value:
- 2021-0075-0010-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-06-29
- Subjects:
- Clinical medicine -- Periodicals
Medicine -- Periodicals
610.5 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://www.blackwell-synergy.com/loi/ijcp ↗
http://www.blackwell-synergy.com/openurl?genre=journal&eissn=1742-1241 ↗
http://www.blackwellpublishing.com/journal.asp?ref=1368-5031&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-1241 ↗
https://www.hindawi.com/journals/ijclp/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/ijcp.14543 ↗
- Languages:
- English
- ISSNs:
- 1368-5031
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.172160
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23798.xml